structuarl variant detection in smrt link powered by pbsv · 2019. 4. 10. · structural variant...

27
For Research Use Only. Not for use in diagnostics procedures. © Copyright 2018 by Pacific Biosciences of California, Inc. All rights reserved. Structural Variant Detection in SMRT Link powered by pbsv

Upload: others

Post on 25-Jan-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

  • For Research Use Only. Not for use in diagnostics procedures. © Copyright 2018 by Pacific Biosciences of California, Inc. All rights reserved.

    Structural Variant Detection in SMRT Link

    powered by pbsv

  • TYPES OF STRUCTURAL VARIATION

    deletion insertion duplication

    inversion translocation repeat expansion

  • VARIATION BETWEEN TWO HUMAN GENOMES

    Huddleston et al. (2017) Genome Research 27(5):677-85.

    vs.

    5×106

    5 Mb 3 Mb 10 Mb

    variants

    basepairs

    affected

    SNVs

    4×105

    structural variantsindels

    2×104

  • STRUCTURAL VARIANTS DETECTED IN A HUMAN GENOME

    4,000

    20,000

    Short reads

    PacBio

    repeats + GC-rich +

    large insertions

    Huddleston et al. (2017) Genome Research 27(5):677-85.

    Seo et al. (2016) Nature 538:243-7.

    Sudmant et al. (2016) Nature 526:75-81.

  • WGS FOR STRUCTURAL VARIANT DISCOVERY

    PacBio Sequel System Short-read NGS

    NGMLR BWA

    pbsv GATK

    IGV IGV

    Structural Variants Small Variants

    Sequencing

    Read Mapping

    Variant Calling

    Visualization

  • WGS FOR STRUCTURAL VARIANT DISCOVERY

    PacBio Sequel System Short-read NGS

    NGMLR BWA

    pbsv GATK

    IGV IGV

    Structural Variants Small Variants

    Sequencing

    Read Mapping

    Variant Calling

    Visualization

  • SEQUENCING

    5 µg DNA

    20 kb shear

    + damage repair

    SMRTbell adapter ligation

    15 kb size selection

    Library Preparation

  • SEQUENCING

    polymerase binding

    Sequel System

    (5 Gb per SMRT Cell)

    Sequencing

  • WGS FOR STRUCTURAL VARIANT DISCOVERY

    PacBio Sequel System Short-read NGS

    NGMLR BWA

    pbsv GATK

    IGV IGV

    Structural Variants Small Variants

    Sequencing

    Read Mapping

    Variant Calling

    Visualization

  • READ MAPPING

    Sedlazeck et al. (2017) bioRxiv. doi:10.1101/169557.

    reference

    biological indel

    PacBio read

    gap size

    penalty convex

    (NGMLR)

    affine

    (BWA)

    NGMLRBWA

  • WGS FOR STRUCTURAL VARIANT DISCOVERY

    PacBio Sequel System Short-read NGS

    NGMLR BWA

    pbsv GATK

    IGV IGV

    Structural Variants Small Variants

    Sequencing

    Read Mapping

    Variant Calling

    Visualization

  • VARIANT CALLING

    http://pacb.com/sv

    FIND SV

    SIGNATURES

    CIGAR D & I

    ≥50 bp

    CLUSTER SV

    SIGNATURES

    nearby with

    similar sequence

    FILTER≥2 and ≥20%

    reads support

    SUMMARIZE

    INTO SV

    consensus of

    supporting reads

    GENOTYPEsupporting reads /

    covering reads

  • VARIANT CALLING

    http://pacb.com/sv

    FIND SV

    SIGNATURES

    CIGAR D & I

    ≥50 bp

    CLUSTER SV

    SIGNATURES

    nearby with

    similar sequence

    FILTER≥2 and ≥20%

    reads support

    SUMMARIZE

    INTO SV

    consensus of

    supporting reads

    GENOTYPEsupporting reads /

    covering reads

  • VARIANT CALLING

    http://pacb.com/sv

    FIND SV

    SIGNATURES

    CIGAR D & I

    ≥50 bp

    CLUSTER SV

    SIGNATURES

    nearby with

    similar sequence

    FILTER≥2 and ≥20%

    reads support

    SUMMARIZE

    INTO SV

    consensus of

    supporting reads

    GENOTYPEsupporting reads /

    covering reads

  • VARIANT CALLING

    http://pacb.com/sv

    FIND SV

    SIGNATURES

    CIGAR D & I

    ≥50 bp

    CLUSTER SV

    SIGNATURES

    nearby with

    similar sequence

    FILTER≥2 and ≥20%

    reads support

    SUMMARIZE

    INTO SV

    consensus of

    supporting reads

    GENOTYPEsupporting reads /

    covering reads

    4 of 101 of 10

  • VARIANT CALLING

    http://pacb.com/sv

    FIND SV

    SIGNATURES

    CIGAR D & I

    ≥50 bp

    CLUSTER SV

    SIGNATURES

    nearby with

    similar sequence

    FILTER≥2 and ≥20%

    reads support

    SUMMARIZE

    INTO SV

    consensus of

    supporting reads

    GENOTYPEsupporting reads /

    covering reads

    329 bp deletion

    4 of 101 of 10

  • VARIANT CALLING

    http://pacb.com/sv

    FIND SV

    SIGNATURES

    CIGAR D & I

    ≥50 bp

    CLUSTER SV

    SIGNATURES

    nearby with

    similar sequence

    FILTER≥2 and ≥20%

    reads support

    SUMMARIZE

    INTO SV

    consensus of

    supporting reads

    GENOTYPEsupporting reads /

    covering reads

    329 bp deletion

    4 of 101 of 10

    heterozygous (4 of 10)

  • VARIANT CALLING

    SMRT Analysis SMRT Analysis

    chr1

    904490

    ACGCGGCCGCCTCCTCCTCCGAACGTGGCCTCCTCCGAACGCGGCCGCCTCCTCCTCCGAACGCGGCCGCCTCCTCCTCCGA

    A

    PASS

    IMPRECISE;SVTYPE=DEL;END=904587;SVLEN=-97;SVANN=TANDEM

    GT:AD:DP

    0/1:9:15

    SMRT Analysis SMRT Analysis

  • WGS FOR STRUCTURAL VARIANT DISCOVERY

    PacBio Sequel System Short-read NGS

    NGMLR BWA

    pbsv GATK

    IGV 2.4 IGV

    Structural Variants Small Variants

    Sequencing

    Read Mapping

    Variant Calling

    Visualization

  • VISUALIZATION

    Robinson et al. (2011) Nature Biotechnology. doi:10.1038/nbt.1754.

    insertion

    deletion

  • WGS FOR STRUCTURAL VARIANT DISCOVERY

    PacBio Sequel System Short-read NGS

    NGMLR BWA

    pbsv GATK

    IGV 2.4 IGV

    Structural Variants Small Variants

    Sequencing

    Read Mapping

    Variant Calling

    Visualization

  • HOW MUCH TO SEQUENCE?

    0%

    10%

    20%

    30%

    40%

    50%

    60%

    70%

    80%

    90%

    100%

    0 10 20 30 40 50

    % S

    Vs d

    ete

    cte

    d

    Coverage

    Het

    Hom

    short read

    30- to 40-fold

    saturate discovery

    de novo variant discovery

    5- to 10-fold

    optimal tradeoff of

    cost vs. performance

    disease gene discovery;

    population characterization

    Human HG00733

    Sequel System

    211 Gb (70-fold)

  • CLINICAL CASE HISTORY

    Merker et al. (2017) Genetics in Medicine. doi:10.1038/gim.2017.86.

    7 yrsleft atrial myxoma resection,

    atrial repair

    10 yrstesticular mass,

    right orchiectomy

    13 yrs pituitary tumor

    16 yrsrecurrence of myxomata, resection,

    adrenal microadenoma

    18 yrsrecurrence of ventricular myxomata,

    resection, VT

    19 yrsACTH-independent Cushing’s disease,

    thyroid nodules

    21 yrs transphenoidal resection of pituitary

    present

    (26 yrs)

    recurrence of myxomata, consideration

    for heart transplant

    genetics suggests Carney complex

    PRKAR1A testing negative

    short-read whole genome

    sequencing negative

  • EVALUATING STRUCTURAL VARIANTS

    Merker et al. (2017) Genetics in Medicine. doi:10.1038/gim.2017.86.

    Deletions Insertions

    Initial call set 6,971 6,821

    Not in segdup 5,893 6,254

    Not in NA12878

    “healthy” control2,476 3,171

    Overlaps RefSeq

    coding exon39 16

    Gene linked to some

    disease in OMIM3 3

    0%

    10%

    20%

    30%

    40%

    50%

    60%

    70%

    80%

    90%

    100%

    0 10 20 30 40 50%

    SV

    s d

    ete

    cte

    d

    Coverage

    Het

    Hom

    8-fold

  • HETEROZYGOUS 2.2 KB DELETION IN PRKAR1A

    Merker et al. (2017) Genetics in Medicine. doi:10.1038/gim.2017.86.

    PacBio

    discovery

    Sanger

    confirmation

  • For Research Use Only. Not for use in diagnostics procedures. © Copyright 2017 by Pacific Biosciences of California, Inc. All rights reserved. Pacific Biosciences, the Pacific Biosciences logo,

    PacBio, SMRT, SMRTbell, Iso-Seq, and Sequel are trademarks of Pacific Biosciences. BluePippin and SageELF are trademarks of Sage Science. NGS-go and NGSengine are trademarks of GenDx.

    FEMTO Pulse and Fragment Analyzer are trademarks of Advanced Analytical Technologies.

    All other trademarks are the sole property of their respective owners.

    www.pacb.com